Patents from our own research in clinical, device, trials, insurance, and transaction systems

A patent here does one of three jobs. It protects a technique we proved in the field and intend to keep using. It makes that technique licensable, so a health system or device maker can adopt it with clear terms instead of guessing. Or it keeps ground open, by making sure the plumbing everyone depends on cannot be fenced off by someone who never built it.

Filings that stop doing one of those jobs get abandoned rather than renewed out of habit. A claim nobody here can connect to a product costs money every year and earns nothing.

The usual route is a field-of-use license. The buyer names the market and the product, we grant rights inside that field, and both sides write down the term, the diligence obligations, and what happens if the product never ships. Remote monitoring can be licensed without touching claims adjudication.

Families we no longer need to hold are available to buy outright. Where that is true, we say so plainly instead of renting out an asset we have no intention of maintaining.

Co-development is the third route: a license paired with operators from Intellectual Frontiers Studios who have been through an FDA submission, a payer integration, or a state modernization.

To start, send the product, the market, whether exclusivity matters, and the ship date to hello+patents@intellectualfrontiers.com. One paragraph is enough to get a real answer.

Engineering teams do not need permission to start reading. Each family page lists every filing, the status the USPTO reports, and a link to the full document, so a team can evaluate the claims before anyone involves counsel.

The defensive disclosures are free to use by design, and the summaries explain coverage in language a product or procurement team can act on. Teams already building on a claim are better off saying so early. We would rather license than litigate.